Compounds > vadimezan
Page last updated: 2024-09-03

vadimezan and digoxin

vadimezan has been researched along with digoxin in 1 studies

Compound Research Comparison

Studies
(vadimezan)		Trials
(vadimezan)		Recent Studies (post-2010)
(vadimezan)		Studies
(digoxin)		Trials
(digoxin)		Recent Studies (post-2010) (digoxin)
2721610111,4839581,289

Protein Interaction Comparison

ProteinTaxonomyvadimezan (IC50)digoxin (IC50)
STAT3, partialHomo sapiens (human)1.862
Sodium/potassium-transporting ATPase subunit alpha-1 Homo sapiens (human)0.32
Sodium/potassium-transporting ATPase subunit beta-1Homo sapiens (human)0.335
Sodium/potassium-transporting ATPase subunit alpha-2Rattus norvegicus (Norway rat)0.22
Sodium/potassium-transporting ATPase subunit alpha-3 Rattus norvegicus (Norway rat)0.22
Sodium/potassium-transporting ATPase subunit beta-1 Rattus norvegicus (Norway rat)0.0055
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.19
Sodium/potassium-transporting ATPase subunit alpha-3Homo sapiens (human)0.335
Sodium/potassium-transporting ATPase subunit beta-2Homo sapiens (human)0.335
Sodium/potassium-transporting ATPase subunit alpha-2Homo sapiens (human)0.335
Sodium/potassium-transporting ATPase subunit alpha-1Canis lupus familiaris (dog)0.5
Nuclear receptor ROR-gammaHomo sapiens (human)3.4798
Sodium/potassium-transporting ATPase subunit beta-3Homo sapiens (human)0.335
Sodium/potassium-transporting ATPase subunit gammaHomo sapiens (human)0.335
Sodium/potassium-transporting ATPase subunit alpha-4Homo sapiens (human)0.335
Sodium/potassium-transporting ATPase subunit alpha-4Rattus norvegicus (Norway rat)0.0055
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)3.2359

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cichoń, T; Jarosz-Biej, M; Kułach, N; Pilny, E; Poczkaj, A; Smolarczyk, R; Szala, S1

Other Studies

1 other study(ies) available for vadimezan and digoxin

ArticleYear
Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors.
    Scientific reports, 2018, 05-09, Volume: 8, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Digoxin; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophages; Melanoma; Melanoma, Experimental; Mice; Neovascularization, Pathologic; Xanthones; Xenograft Model Antitumor Assays

2018